Nurix Therapeutics Debt-to-Assets Ratio Growth & History (NRIX)

Nurix Therapeutics's debt-to-assets ratio was 0.08 for fiscal 2025.

View full Nurix Therapeutics company overview

Nurix Therapeutics annual debt-to-assets ratio history

Nurix Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-11-300.080.04+91.53%
20242024-11-300.04−0.04−50.88%
20232023-11-300.090.06+199.90%
20222022-11-300.030.00+4.99%
20212021-11-300.03

Nurix Therapeutics debt-to-assets ratio trends

Between the periods ended 2021-11-30 and 2025-11-30, Nurix Therapeutics's debt-to-assets ratio increased from 0.03 to 0.08, a change of 0.05. The latest reported quarter, Q2 2026, shows 0.11.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nurix Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about NRIX yet. Start the conversation.

Write the first post